Beyond development: Global disparities in gastrointestinal cancer outcomes across 176 countries.
MIR-based analysis across 176 countries identified substantial global heterogeneity in GI cancer outcomes beyond what HDI predicts, and Japan's consistently negative SAG and the paradoxically positive SAG of several high-income countries suggest that factors not captured by composite development indices may be associat...